Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 27.85 is 273% above its 5-year average of 7.47, near the high end of its 5-year range (0.00–27.85).
As of the fiscal period ended Tuesday, June 30, 2026. 142.20% above its 12-month average of 11.50.
Reported quarterly current ratio; no daily interpolation. Q4 FY2026 (2026-06-30): 27.85.
CURRENT RATIO
27.85
CURRENT RATIO AVG TTM
11.50
CURRENT RATIO AVG 3Y
5.12
CURRENT RATIO AVG 5Y
7.47
CURRENT RATIO AVG 10Y
5.38
CURRENT RATIO AVG 15Y
3.98
CURRENT RATIO AVG 20Y
3.78
CURRENT VS TTM AVG
+142.20%
CURRENT VS 3Y AVG
+443.87%
CURRENT VS 5Y AVG
+272.90%
CURRENT VS 10Y AVG
+417.50%
CURRENT VS 15Y AVG
+599.00%
CURRENT VS 20Y AVG
+636.27%
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+642.59%
vs the sector median at left
Neuphoria Therapeutics Inc.
Market Cap
$18.62M
Current Ratio
27.85
TTM Avg
11.50
3Y Avg
5.12
5Y Avg
7.47
Market Cap
$19.28M
Current Ratio
1.25
TTM Avg
1.72
3Y Avg
2.15
5Y Avg
2.15
Market Cap
$18.18M
Current Ratio
0.20
TTM Avg
0.34
3Y Avg
6.34
5Y Avg
6.11
Market Cap
$17.14M
Current Ratio
4.61
TTM Avg
2.49
3Y Avg
1.77
5Y Avg
2.58
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | $18.62M | 27.85 | 11.50 | 5.12 | 7.47 |
| Cosmos Health Inc. (COSM)vs › | $17.32M | 1.05 | 0.99 | 1.52 | 1.43 |
| Actuate Therapeutics Inc (ACTU)vs › | $19.28M | 1.25 | 1.72 | 2.15 | 2.15 |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.18M | 0.20 | 0.34 | 6.34 | 6.11 |
| P3 Health Partners Inc. (PIII)vs › | $17.46M | 0.46 | 0.30 | 0.39 | 0.60 |
| PAVmed Inc. (PAVM)vs › | $17.23M | 1.19 | 0.12 | 0.44 | 2.27 |
| Lipocine Inc. (LPCN)vs › | $17.19M | 11.48 | 10.71 | 12.62 | 10.43 |
| Palatin Technologies, Inc. (PTN)vs › | $17.14M | 4.61 | 2.49 | 1.77 | 2.58 |
| Quantum BioPharma Ltd. (QNTM)vs › | $20.16M | 1.20 | 1.44 | 1.90 | 2.95 |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.01M | 6.03 | 7.38 | 5.62 | 4.97 |
Current Ratio
27.85
Quick Ratio
27.85
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 27.85 |
| 2026-03-31 | 14.31 |
| 2025-12-31 | 9.04 |
| 2025-09-30 | 2.72 |
| 2025-06-30 | 3.56 |
| 2025-03-31 | 11.01 |
| 2024-12-31 | 2.06 |
| 2024-09-30 | 3.30 |
| 2024-06-30 | 3.45 |
| 2024-03-31 | 0.00 |
| 2023-12-31 | 3.81 |
| 2023-09-30 | 3.30 |
| 2023-06-30 | 4.87 |
| 2023-03-31 | 4.87 |
| 2022-12-31 | 9.05 |
| 2022-09-30 | 9.05 |
| 2022-06-30 | 12.46 |
| 2022-03-31 | 12.46 |
| 2021-12-31 | 13.46 |
| 2021-09-30 | 13.46 |
| 2021-06-30 | 13.10 |
| 2021-03-31 | 13.10 |
| 2020-12-31 | 0.57 |
| 2020-09-30 | 0.74 |
| 2020-06-30 | 1.01 |
| 2020-03-31 | 1.01 |
| 2019-12-31 | 1.11 |
| 2019-09-30 | 1.11 |
| 2019-06-30 | 1.82 |
| 2019-03-31 | 1.82 |
| 2018-12-31 | 2.49 |
| 2018-09-30 | 2.49 |
| 2018-06-30 | 2.70 |
| 2018-03-31 | 2.70 |
| 2017-12-31 | 6.17 |
| 2017-09-30 | 6.17 |
| 2017-06-30 | 3.92 |
| 2017-03-31 | 3.92 |
| 2016-12-31 | 3.97 |
| 2016-09-30 | 3.97 |
| 2016-06-30 | 5.10 |
| 2016-03-31 | 5.10 |
| 2015-12-31 | 4.19 |
| 2015-09-30 | 4.19 |
| 2015-06-30 | 2.76 |
| 2015-03-31 | 2.76 |
| 2014-12-31 | 5.38 |
| 2014-09-30 | 5.38 |
| 2014-06-30 | 4.26 |
| 2013-12-31 | 4.65 |
| 2013-06-30 | 5.05 |
| 2012-12-31 | 4.51 |
| 2012-06-30 | 4.87 |
| 2011-12-31 | 6.72 |
| 2011-06-30 | 4.54 |
| 2010-12-31 | 5.48 |
| 2010-06-30 | 4.29 |
| 2009-12-31 | 7.16 |
| 2009-06-30 | 2.11 |
| 2008-12-31 | 1.66 |
| 2008-06-30 | 2.90 |
| 2007-12-31 | 3.32 |
| 2007-06-30 | 3.86 |
| 2006-12-31 | 2.86 |
| 2006-06-30 | 1.92 |
| 2005-12-31 | 3.20 |
| 2005-06-30 | 4.64 |
| 2004-12-31 | 4.35 |
| 2004-06-30 | 6.38 |
| 2003-12-31 | 2.91 |
| 2003-06-30 | 5.04 |
| 2002-06-30 | 10.48 |
| 2001-06-30 | 16.82 |
